Ariane Laparra

Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer

Audrey Simonaggio, Jean‐Marie Michot, Anne Laure Voisin et al. · JAMA Oncology · 2019 · 354 citations · Full text

The determinants of very severe immune-related adverse events associated with immune checkpoint inhibitors: A prospective study of the French REISAMIC registry

Valentine Ruste, Vincent Goldschmidt, Ariane Laparra et al. · European Journal of Cancer · 2021 · 77 citations

Allergy, Autoimmune Disease, Medicine +12

Toxicity of immunotherapy combinations with chemotherapy across tumor indications: Current knowledge and practical recommendations

Layal Rached, Ariane Laparra, Madona Sakkal et al. · Cancer Treatment Reviews · 2024 · 71 citations · Full text

Anti–programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment study

Marion Panhaleux, Olivier Espitia, Benjamin Terrier et al. · European Journal of Cancer · 2021 · 46 citations

Cancer Immunosurveillance, Oncology, Autoimmune Disease +10

Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelae

Léo Plaçais, Jean‐Marie Michot, Stéphane Champiat et al. · Brain Communications · 2021 · 41 citations · Full text